Selinexor selectively targets XPO1 and contributes to the intranuclear storage and activation of tumour suppressor proteins and other growth-regulating proteins, downregulates the levels of multiple oncogenic proteins in the cytoplasm and induces apoptosis of tumour cells [14–16]. Here, XPO1 is linked to neoplasm.